Ivelisse Clausell v. Johnson & Johnson Services, Inc.

CourtDistrict Court, D. New Jersey
DecidedJanuary 15, 2026
Docket3:25-cv-01751
StatusUnknown

This text of Ivelisse Clausell v. Johnson & Johnson Services, Inc. (Ivelisse Clausell v. Johnson & Johnson Services, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ivelisse Clausell v. Johnson & Johnson Services, Inc., (D.N.J. 2026).

Opinion

NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

IVELISSE CLAUSELL, Plaintiff, Civil Action No. 25-1751 (MAS) (TJB) ° MEMORANDUM OPINION JOHNSON & JOHNSON SERVICES, INC., Defendant.

SHIPP, District Judge This matter comes before the Court upon Defendant Johnson & Johnson Services, Inc.’s (“Defendant”) Motion to Dismiss (ECF No. 8) Plaintiff Ivelisse Clausell’s (“Plaintiff”) Amended Complaint (ECF No. 4) and Defendant’s Motion for Sanctions (ECF No. 15). Plaintiff opposed both motions (ECF Nos. 16, 20), and Defendant replied (ECF Nos. 17, 21). The Court has carefully considered the parties’ submissions and decides the matter without oral argument pursuant to Local Civil Rule 78.1. For the reasons stated below, the Court grants in part and denies in part Defendant’s Motion to Dismiss and denies Defendant’s Motion for Sanctions. I. BACKGROUND! A. Factual Background This matter involves an employment discrimination dispute between Plaintiff and Defendant that stems from Plaintiff’s allegations that she was discriminated against when she was passed over for a promotion, and that Defendant retaliated against her after she filed a complaint

' For the purpose of considering the instant motions, the Court accepts all factual allegations in the Amended Complaint as true. See Phillips v. County of Allegheny, 515 F.3d 224, 228 (3d Cir. 2008).

with Human Resources (“HR”) alleging conduct that she believed violated the law. (Compl. {[{ 2-3, 28, ECF No. 4.) Plaintiff’s employment with Defendant began in April 2016 when she joined as Senior Counsel, Privacy Law. Ud. ¥ 5.) Most recently, Plaintiff worked as Vice President of Data Protection Legal (“DPL”) within Defendant’s Global Legal Organization (“GLO”) and Global Privacy Organization (“GPO”). (/d.) During the course of her employment, Plaintiff performed her job well and earned a reputation as a subject matter expert and trusted business partner in privacy. Ud. 16.) Plaintiff left the company in December 2019 and returned in January 2022 as Group Leader, Global Privacy & Cybersecurity Law. Ud. 5.) Plaintiff alleges that Defendant subsequently denied her a promotion to Chief Privacy Officer (“CPO”) based on her ethnicity, race, and gender by pre-selecting an external candidate and failing to provide Plaintiff an opportunity to present her qualifications through the interview process. (/d. § 29.) The hiring manager was Ashley Watson (“Watson”), a woman who is white and the Worldwide Vice President and General Counsel of MedTech Legal and Head of Enterprise Privacy. Ud. | 31.) Watson announced she was looking for three things in a successful candidate for the CPO role: “(1) someone who was a privacy expert; (2) someone who had done the job before; and (3) someone who was ‘delightful.’” ¢d. ¥ 32.) Plaintiff’s qualifications included that: (1) she practiced privacy law for more than fifteen years, had been frequently asked to speak on privacy topics, and had numerous certifications in the privacy area; (2) she had previously worked as CPO at Organon, Global Head of Privacy and Information Security at Esperion Therapeutics, and Senior Compliance Counsel and Privacy Officer at Otsuka Pharmaceutical; and (3) she had received a rating of “exceeds” in the “behaviors” section of her then most recent performance evaluation and was praised by Defendant in a release

announcing her appointment to Group Leader as an “extremely collaborative” employee. □□□□ § 34.) Throughout July 2023, Defendant conducted “a farcical interview process” to fill the position, but the team already knew it would hire Scott Taylor (“Taylor”), a white male external applicant, for the role Ud. 35, 37.) Specifically, on July 5, 2023, Watson interviewed Plaintiff. (id. § 38.) During the interview, Watson stated her preference for Taylor. Ud. J 38.) Plaintiff attended two additional interviews on July 10, 2023: (1) one with the Worldwide Vice President of Regulatory Law; and (2) another with Denise Weber (“Weber”) head of HR, Legal and Government Affairs. (/d. §{ 39.) During the interview, Weber “acknowledged that... Watson had previously informed her that she had a ‘preferred candidate.’” (/d.) Taylor was hired and started as CPO on August 10, 2023. Ud. ¢ 41.) After Taylor’s hire, he engaged in allegedly unethical practices that Plaintiff believes violated the law, including the New Jersey Trade Secrets Act and the Defend Trade Secrets Act. (id. § 43.) Plaintiff became concerned that Taylor was misappropriating trade secrets from his former employer, Merck & Co. (“Merck”), where Plaintiff had also previously worked. (/d. § 44.) Specifically, Plaintiff was concerned that Taylor was improperly using confidential information and documents belonging to Merck to complete his work for Defendant, including copying and pasting confidential work product and information from Merck-branded documents into documents and presentations for Defendant. (/d.) Taylor also “admitted to [Plaintiff] during a [one on one] meeting that he had ‘the whole Privacy Rulebook’ from Merck.” (Ud. § 46.) Taylor continues to use Merck’s property in his work for Defendant. (/d.) Taylor, thereafter, hired Raymond Farraro (“Farraro”), another white male, and his previous employee at both Merck and Hewlett-Packard, for the position of Senior Director, Global

Privacy Governance and Assurance. (id. § 47, 48.) Since beginning his employment with Defendant, Farraro has converted several Merck documents to Defendant’s branding by changing the font colors. Ud. § 49.) Farraro has also stated several times that some of the documents may have “Merck words” or that he may have forgotten to put something into Defendant’s format and instructed other employees to change the Merck references to references about Defendant. □□□□ Plaintiff alleges this conduct “implicated [Defendant] in violating several intellectual property laws.” id.) On May 17, 2024, Plaintiff filed an official report with Weber from HR, after speaking to Weber about her concerns on May 14, 2024. Ud. ¥ 52.) In the report, Plaintiff reported that Taylor and Farraro had brought proprietary documents with them from Merck. (/d.) Plaintiff filed the report to ensure Defendant’s compliance with intellectual property laws and ethical practices. (/d.) Weber, however, “strategically delayed the submission of [Plaintiff’s report], and... on June 19, 2024, .. . informed [Plaintiff] that she had filed the [report] ‘anonymously,’ although” they had “previously agreed . . . that the complaint would be filed in [Plaintiff’s] name.” (Ud. § 54.) After May 2024, Plaintiff “provided additional information to support her [report] to... Weber and... Kerri Loiselle” (“Loiselle”), “Senior Manager, Employee & Labor Relations, who was eventually assigned to investigate the . . . complaint.” Ud. 4 55.) Loiselle contacted Plaintiff on July 9, 2024.

Six weeks after Plaintiff filed her report, Plaintiff had her mid-year performance review with Taylor and Watson. Ud. □ 57.) During the meeting, Watson and Taylor stated that Defendant was reorganizing, and that Plaintiff’s role would be eliminated as part of the reorganization. (/d. { 62.) Plaintiff alleges that this was done in retaliation for filing her complaint. (/d. 4 63.) On September 26, 2024, Watson and Weber met with Plaintiff for a “[ninety]-day . . . discussion under

the New Jersey WARN Act” informing Plaintiff that her termination date was December 27, 2024. (d. § 64.) Plaintiff’s annual bonus was also cut by fifty percent without explanation. (/d. { 68.) On September 30, 2024, Loiselle discussed the results of her investigation into Plaintiff's complaint and confirmed that she found that Merck materials were used but that Defendant determined their usage was not improper. (/d. J 65.) B.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Ryan Brown v. City of Long Branch
380 F. App'x 235 (Third Circuit, 2010)
Karen Malleus v. John George
641 F.3d 560 (Third Circuit, 2011)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Sarnowski v. Air Brooke Limousine, Inc.
510 F.3d 398 (Third Circuit, 2007)
Makky v. Chertoff
541 F.3d 205 (Third Circuit, 2008)
Maimone v. City of Atlantic City
903 A.2d 1055 (Supreme Court of New Jersey, 2006)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Viscik v. Fowler Equipment Co., Inc.
800 A.2d 826 (Supreme Court of New Jersey, 2002)
Pierce v. Ortho Pharmaceutical Corp.
417 A.2d 505 (Supreme Court of New Jersey, 1980)
Tartaglia v. UBS PaineWebber Inc.
961 A.2d 1167 (Supreme Court of New Jersey, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Ivelisse Clausell v. Johnson & Johnson Services, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/ivelisse-clausell-v-johnson-johnson-services-inc-njd-2026.